229 related articles for article (PubMed ID: 22093223)
1. Nanobiotechnology and personalized medicine.
Jain KK
Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine: application of nanobiotechnology in medical practice.
Jain KK
Med Princ Pract; 2008; 17(2):89-101. PubMed ID: 18287791
[TBL] [Abstract][Full Text] [Related]
3. The role of nanobiotechnology in the development of personalized medicine.
Jain KK
Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206
[No Abstract] [Full Text] [Related]
4. The role of nanobiotechnology in drug discovery.
Jain KK
Drug Discov Today; 2005 Nov; 10(21):1435-42. PubMed ID: 16243263
[TBL] [Abstract][Full Text] [Related]
5. Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
Jain KK
Nanomedicine (Lond); 2011 Apr; 6(3):411-4. PubMed ID: 21542679
[No Abstract] [Full Text] [Related]
6. The role of nanobiotechnology in drug discovery.
Jain KK
Adv Exp Med Biol; 2009; 655():37-43. PubMed ID: 20047033
[TBL] [Abstract][Full Text] [Related]
7. Role of nanobiotechnology in the development of personalized medicine.
Jain KK
Nanomedicine (Lond); 2009 Apr; 4(3):249-52. PubMed ID: 19331532
[No Abstract] [Full Text] [Related]
8. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
Emerich DF; Thanos CG
Biomol Eng; 2006 Sep; 23(4):171-84. PubMed ID: 16843058
[TBL] [Abstract][Full Text] [Related]
9. Role of nanodiagnostics in personalized cancer therapy.
Jain KK
Clin Lab Med; 2012 Mar; 32(1):15-31. PubMed ID: 22340841
[No Abstract] [Full Text] [Related]
10. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
11. Nanopediatrics: enabling personalized medicine for children.
McCabe ER
Pediatr Res; 2010 May; 67(5):453-7. PubMed ID: 20118826
[TBL] [Abstract][Full Text] [Related]
12. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
13. Role of nanobiotechnology in developing personalized medicine for cancer.
Jain KK
Technol Cancer Res Treat; 2005 Dec; 4(6):645-50. PubMed ID: 16292884
[TBL] [Abstract][Full Text] [Related]
14. Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine.
Fisher E; Boenink M; van der Burg S; Woodbury N
Expert Rev Mol Diagn; 2012 Nov; 12(8):857-70. PubMed ID: 23249203
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
16. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
17. Omics-based nanomedicine: the future of personalized oncology.
Rosenblum D; Peer D
Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
[TBL] [Abstract][Full Text] [Related]
18. Exploring emerging nanobiotechnology drugs and medical devices.
Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
[No Abstract] [Full Text] [Related]
19. [Nanomedicine as the basis of personalised medicine].
Wojnicz R
Kardiol Pol; 2011; 69(10):1107-8. PubMed ID: 22006624
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine in cardiovascular therapy: recent advancements.
Binsalamah ZM; Paul A; Prakash S; Shum-Tim D
Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
